drugset / Trial / NCT01758055

Safety Study of Endobronchial Transplantation of Autologous Mesenchymal Stem Cells (MSCs) in Emphysema Patients

NCT01758055 ↗

Phase 1 Unknown 12 enrolled Arda Kiani Royan Institute · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is evaluating the safety of endobronchial transplantation of autologous mesenchymal stem cells derived bone marrow in patients with emphysema.

Timeline

Start
2012-12
Primary completion
2013-12
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous mesenchymal stem cells Cell therapy 6e+07 cells Other

Indications